Yi-ran Li - Gynecology

Author Information

Dr. Yiran Li is affiliated with the Department of Gynecology at Shanghai First Maternity and Infant Hospital, which is part of the Tongji University School of Medicine. Located at No. 2699, West GaoKe Road, Pudong District, Shanghai, People's Republic of China, the hospital is a prominent institution in the field of gynecology. Dr. Li's research and clinical work are primarily focused on endometrial cancer, contributing significantly to the understanding and treatment of this condition.

Research Contributions

Dr. Yiran Li has made substantial contributions to the field of gynecology, particularly in the study of endometrial cancer. Her research spans various aspects of this disease, including the tumor immune microenvironment, microbiome interactions, genetic mutations, and signaling pathways. Some noteworthy studies include the integrated analysis of microbiome and transcriptome data, the identification of immune cells producing interleukin-9, and the investigation of POLE mutation characteristics in a Chinese cohort. Dr. Li's work has been pivotal in advancing the understanding of endometrial carcinoma and exploring potential biomarkers and therapeutic targets.

Aliases

Yiran Li is also known by the aliases Yi-ran Li and Yiran Li.

Publication and Citation Metrics

Metric	Value
Citation Count	362
h-index	13
Paper Count	26

Publications:

Integrated Analysis of Microbiome and Transcriptome Data Reveals the Interplay Between Commensal Bacteria and Fibrin Degradation in Endometrial Cancer

DOI: 10.3389/fcimb.2021.748558

Year: 2021

Endometrial Tumors with MSI-H and dMMR Share a Similar Tumor Immune Microenvironment

DOI: 10.2147/OTT.S324641

Year: 2021

Phenotyping of immune and endometrial epithelial cells in endometrial carcinomas revealed by single-cell RNA sequencing

DOI: 10.18632/aging.202288

Year: 2021

Identification of Interleukin-9 Producing Immune Cells in Endometrial Carcinoma and Establishment of a Prognostic Nomogram

DOI: 10.3389/fimmu.2020.544248

Year: 2020

POLE Mutation Characteristics in a Chinese Cohort with Endometrial Carcinoma

DOI: 10.2147/OTT.S258642

Year: 2020

Collagen triple helix repeat containing 1 promotes endometrial cancer cell migration by activating the focal adhesion kinase signaling pathway

DOI: 10.3892/etm.2020.8833

Year: 2020

Correction: AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma

DOI: 10.18632/oncotarget.27359

Year: 2020

Exploration of a Novel Biomarker in Endometrial Carcinoma

DOI: 10.21203/rs.3.rs-101155/v1

Year: 2020

Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway

DOI: 10.3892/or.2020.7478

Year: 2020

ITE, an endogenous aryl hydrocarbon receptor ligand, suppresses endometrial cancer cell proliferation and migration.

DOI: 10.1016/j.tox.2019.03.017

Year: 2019

How can one become a member of ACOG?

Why is it Important for Gynecologists?

What are ovarian cysts and how are they treated?

What Are the Symptoms and Signs?

How is Perinatal Anxiety Diagnosed?

How do Hormones Affect Vaginal Health?

What Are the Effects on Sexual Health?

Why is D&C performed?

How does alcohol consumption affect liver and gynecological health?

Why is a CT Scan Used in Gynecology?

Partnered Content Networks

Relevant Topics